Stock Events

Stock Events

K Pharma 

¥695
5
-¥13-1.84% 06:25 Today

Statistics

Day High
700
Day Low
680
52W High
949
52W Low
610
Volume
13,800
Avg. Volume
19,341
Mkt Cap
8.08B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 13Expected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-26
-23
-20
-17
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2022
2023
2024
2025
2026
0Revenue
-492.7MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4896.TSE. It's not an investment recommendation.
Sumitomo Chemical Company Limited
3
4005.TSE
Toray Industries
3
3402.TSE
Cyberdyne
3
7779.TSE
Nippon Coke & Engineering Company
3
3315.TSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Co., Ltd. - A major Japanese pharmaceutical company directly competing in multiple therapeutic areas similar to K Pharma.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. - Known for its biopharmaceuticals and therapeutic proteins, directly competing with K Pharma's biologic products.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. - Competes in the neurology and oncology sectors, similar to K Pharma's focus areas.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited - Competes directly with K Pharma in the development of novel pharmaceuticals and oncology drugs.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. - Focuses on niche areas like nephrology and immunology, overlapping with K Pharma's specialty areas.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. - Engages in the manufacture and sale of pharmaceuticals, competing in similar therapeutic areas as K Pharma.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. - Offers products in psychiatry and neurology, competing with K Pharma's CNS and mental health drugs.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. - A competitor in the areas of urology and immunology, directly challenging K Pharma's product lines.
Sumitomo Pharma.
4506.TSE
Mkt Cap419.94B
Sumitomo Pharma Co., Ltd. - Competes in the CNS sector, which is a key area for K Pharma.
Nippon Shinyaku.
4516.TSE
Mkt Cap517.95B
Nippon Shinyaku Co., Ltd. - Competes in the pharmaceutical market with a focus on specialty and rare diseases, similar to K Pharma's strategic interests.

About

K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
Show More
CEO
Komei Fukushima
Employees
20
Country
Japan
ISIN
JP3280900006

Listings

TSE
JP
4896.TSE

0 Comments

Share your thoughts

FAQs

What is K Pharma stock price today?▼
The current price of 4896.TSE is ¥695 JPY — it has decreased by -1.84% in the past 24 hours. Watch K Pharma stock price performance more closely on the chart.
What is K Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange K Pharma stocks are traded under the ticker 4896.TSE.
Is K Pharma stock price growing?▼
4896.TSE stock has fallen by -0.29% compared to the previous week, the month change is a -7.33% fall, over the last year K Pharma has showed a +11.02% increase.
What is K Pharma market cap?▼
Today K Pharma has the market capitalization of 8.08B
When is the next K Pharma earnings date?▼
K Pharma is going to release the next earnings report on November 13, 2026.
What were K Pharma earnings last quarter?▼
4896.TSE earnings for the last quarter are -20 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is K Pharma revenue for the last year?▼
K Pharma revenue for the last year amounts to 0 JPY.
What is K Pharma net income for the last year?▼
4896.TSE net income for the last year is -492.7M JPY.
How many employees does K Pharma have?▼
As of November 2, 2026, the company has 20 employees.
In which sector is K Pharma located?▼
K Pharma operates in the Health & Wellness sector.
When did K Pharma complete a stock split?▼
K Pharma has not had any recent stock splits.
Where is K Pharma headquartered?▼
K Pharma is headquartered in Tokyo, Japan.